MetLife Investment Management’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.8M Buy
257,369
+225,329
+703% +$14.9M 0.08% 224
2026
Q1
$2.21M Sell
32,040
-638
-2% -$49.8K 0.01% 1009
2025
Q4
$2.88M Sell
32,678
-1,573
-5% -$134K 0.01% 888
2025
Q3
$2.85M Sell
34,251
-603
-2% -$52.5K 0.01% 912
2025
Q2
$3.26M Sell
34,854
-3,897
-10% -$369K 0.02% 772
2025
Q1
$4.1M Buy
38,751
+4,166
+12% +$430K 0.02% 721
2024
Q4
$3.35M Buy
34,585
+1,557
+5% +$155K 0.02% 781
2024
Q3
$3.26M Hold
33,028
– – 0.02% 772
2024
Q2
$2.84M Buy
33,028
+3,649
+12% +$287K 0.02% 809
2024
Q1
$2.23M Sell
29,379
-594
-2% -$45.9K 0.02% 908
2023
Q4
$2.28M Hold
29,973
– – 0.02% 895
2023
Q3
$2.07M Hold
29,973
– – 0.02% 889
2023
Q2
$2.51M Buy
29,973
+757
+3% +$61.6K 0.02% 842
2023
Q1
$2.16M Sell
29,216
-540
-2% -$37.9K 0.02% 885
2022
Q4
$2.1M Hold
29,756
– – 0.02% 877
2022
Q3
$1.68M Buy
29,756
+1,163
+4% +$67K 0.01% 952
2022
Q2
$1.55M Hold
28,593
– – 0.01% 1003
2022
Q1
$1.9M Buy
28,593
+10,143
+55% +$610K 0.01% 1018
2021
Q4
$1.15M Hold
18,450
– – 0.01% 1072
2021
Q3
$1.32M Hold
18,450
– – 0.01% 1004
2021
Q2
$1.19M Sell
18,450
-3,158
-15% -$195K 0.01% 1079
2021
Q1
$1.29M Hold
21,608
– – 0.01% 1022
2020
Q4
$1.2M Sell
21,608
-1,953
-8% -$101K 0.01% 1047
2020
Q3
$1.02M Hold
23,561
– – 0.01% 1014
2020
Q2
$1.08M Hold
23,561
– – 0.01% 1000
2020
Q1
$736K Hold
23,561
– – 0.01% 1028
2019
Q4
$736K Hold
23,561
– – 0.01% 1254
2019
Q3
$718K Hold
23,561
– – 0.01% 1227
2019
Q2
$1.4M Sell
23,561
-47,122
-67% -$2.7M 0.02% 965
2019
Q1
$4.37M Buy
70,683
+47,122
+200% +$2.67M 0.01% 912
2018
Q4
$1.31M Hold
23,561
– – 0.02% 927
2018
Q3
$1.45M Buy
23,561
+251
+1% +$14.4K 0.01% 986
2018
Q2
$1.19M Hold
23,310
– – 0.01% 955
2018
Q1
$1.06M Hold
23,310
– – 0.01% 985
2017
Q4
$1.01M Buy
+23,310
New +$978K 0.01% 1031

Other funds holding MMSI

MetLife Investment Management's MMSI Position: Q2 2026 in Review

MetLife Investment Management increased its Merit Medical Systems (MMSI) stake by 703% in Q2 2026, buying an estimated $14.9M and bringing the position to 257,369 shares worth $17.8M. The position accounts for 0.08% of the portfolio, ranked #224.

MetLife Investment Management first reported a position in MMSI in Q4 2017 and has held it in 35 quarters since. 405 funds tracked by Wall St. Rank hold MMSI as of Q2 2026.

  • MetLife Investment Management held 257,369 shares of Merit Medical Systems worth $17.8M as of Q2 2026.
  • MetLife Investment Management bought 225,329 Merit Medical Systems shares in Q2 2026, an estimated $14.9M.
  • Merit Medical Systems made up 0.08% of MetLife Investment Management's portfolio in Q2 2026, its #224 holding.
  • MetLife Investment Management first reported a position in Merit Medical Systems in Q4 2017 and has held it in 35 quarters since.
  • 405 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.